Correlation Between Processa Pharmaceuticals and Alpha Cognition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Alpha Cognition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Alpha Cognition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and Alpha Cognition, you can compare the effects of market volatilities on Processa Pharmaceuticals and Alpha Cognition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Alpha Cognition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Alpha Cognition.

Diversification Opportunities for Processa Pharmaceuticals and Alpha Cognition

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Processa and Alpha is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Alpha Cognition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Cognition and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Alpha Cognition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Cognition has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Alpha Cognition go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Alpha Cognition

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Alpha Cognition. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 4.29 times less risky than Alpha Cognition. The stock trades about -0.03 of its potential returns per unit of risk. The Alpha Cognition is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  702.00  in Alpha Cognition on August 25, 2024 and sell it today you would lose (127.00) from holding Alpha Cognition or give up 18.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Processa Pharmaceuticals  vs.  Alpha Cognition

 Performance 
       Timeline  
Processa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Alpha Cognition 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Cognition are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Alpha Cognition reported solid returns over the last few months and may actually be approaching a breakup point.

Processa Pharmaceuticals and Alpha Cognition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Processa Pharmaceuticals and Alpha Cognition

The main advantage of trading using opposite Processa Pharmaceuticals and Alpha Cognition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Alpha Cognition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Cognition will offset losses from the drop in Alpha Cognition's long position.
The idea behind Processa Pharmaceuticals and Alpha Cognition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios